Author: Saeed, Abdullah F. U. H.; Wang, Rongzhi; Ling, Sumei; Wang, Shihua
Title: Antibody Engineering for Pursuing a Healthier Future Document date: 2017_3_28
ID: 0fegsm1v_109
Snippet: Natural killer (NK) cells exhibit essential role in immunity in the context of mAb treatment by exerting direct cytotoxicity toward infected or tumor cells and contributing in modeling the adaptive response (Cheng et al., 2013) . Several T-or NK-cell modulators such as ipilimumab and nivolumab were approved for the treatment of metastatic melanoma (Berman et al., 2015) ......
Document: Natural killer (NK) cells exhibit essential role in immunity in the context of mAb treatment by exerting direct cytotoxicity toward infected or tumor cells and contributing in modeling the adaptive response (Cheng et al., 2013) . Several T-or NK-cell modulators such as ipilimumab and nivolumab were approved for the treatment of metastatic melanoma (Berman et al., 2015) .
Search related documents:
Co phrase search for related documents- adaptive response and immunity essential role: 1, 2
- adaptive response and mAb treatment: 1
- adaptive response and natural killer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- adaptive response and natural killer NK cell: 1
- adaptive response and nk cell: 1, 2, 3, 4, 5, 6, 7, 8
- direct cytotoxicity and natural killer: 1, 2, 3
- direct cytotoxicity and nk cell: 1, 2, 3
- essential role and immunity essential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- essential role and mAb treatment: 1
- essential role and natural killer: 1, 2, 3, 4, 5
- essential role and nk cell: 1, 2, 3
- immunity essential role and mAb treatment: 1
- immunity essential role and natural killer: 1, 2, 3
- immunity essential role and nk cell: 1, 2
- mAb treatment and natural killer: 1
- mAb treatment and nk cell: 1, 2, 3, 4, 5
- metastatic melanoma and nivolumab ipilimumab: 1, 2, 3, 4, 5, 6
- metastatic melanoma treatment and nivolumab ipilimumab: 1, 2, 3, 4
- natural killer and nk cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
Co phrase search for related documents, hyperlinks ordered by date